These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6292251)

  • 21. Purification and quantification of recombinant Epstein-Barr viral glycoproteins gp350/220 from Chinese hamster ovary cells.
    Hessing M; van Schijndel HB; van Grunsven WM; Wolf H; Middeldorp JM
    J Chromatogr; 1992 May; 599(1-2):267-72. PubMed ID: 1320046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat durability of Epstein-Barr virus-activating substances of plant origin: 12-O-tetradecanoylphorbol-13-acetate, 12-O-hexadecanoyl-16-hydrophorbol-13-acetate, croton oil, tung oil and Croton megalocarpus extract.
    Yanase S; Ito Y
    Cancer Lett; 1984 Mar; 22(2):183-6. PubMed ID: 6322973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.
    Ulaeto D; Wallace L; Morgan A; Morein B; Rickinson AB
    Eur J Immunol; 1988 Nov; 18(11):1689-97. PubMed ID: 2904885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
    Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
    J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced expression of Epstein-Barr virus early antigens by antitubulin agents in a latently infected human lymphoblastoid cell line.
    Fujita J; Yoshida O; Tokuda H; Sugawara K; Ito Y
    Experientia; 1985 Mar; 41(3):372-3. PubMed ID: 2982647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.
    Rowe M; Evans HS; Young LS; Hennessy K; Kieff E; Rickinson AB
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1575-86. PubMed ID: 2438376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strains.
    Dölken G; Klein G
    Virology; 1976 Mar; 70(1):210-3. PubMed ID: 176804
    [No Abstract]   [Full Text] [Related]  

  • 28. Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector.
    Finerty S; Tarlton J; Mackett M; Conway M; Arrand JR; Watkins PE; Morgan AJ
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():449-53. PubMed ID: 1311367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralization.
    Yao QY; Rowe M; Morgan AJ; Sam CK; Prasad U; Dang H; Zeng Y; Rickinson AB
    Int J Cancer; 1991 Apr; 48(1):45-50. PubMed ID: 1850382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of 12-o-tetradecanoylphorbol-13-acetate-induced cellular proteins that compete with the Epstein-Barr virus nuclear antigen 1 (EBNA-1) for binding to a site within the Epstein-Barr virus oriP.
    Nonoyama M; Wen LT; Tanaka A; Bradley G
    Adv Exp Med Biol; 1990; 278():125-36. PubMed ID: 1963029
    [No Abstract]   [Full Text] [Related]  

  • 31. The Epstein-Barr virus proteins.
    Dillner J; Kallin B
    Adv Cancer Res; 1988; 50():95-158. PubMed ID: 2837072
    [No Abstract]   [Full Text] [Related]  

  • 32. A simple method for immune analysis of proteins following sodium dodecyl sulphate polyacrylamide gel electrophoresis.
    Cleator GM; Klapper PE; Cropper LM; Coupes D; Longson M
    J Immunol Methods; 1984 Mar; 67(2):347-51. PubMed ID: 6323580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways.
    Lee SP; Wallace LE; Mackett M; Arrand JR; Searle PF; Rowe M; Rickinson AB
    Int Immunol; 1993 May; 5(5):451-60. PubMed ID: 8391306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical characterization of two Epstein-Barr virus early antigen-associated phosphopolypeptides.
    Roeckel D; Mueller-Lantzsch N
    Virology; 1985 Dec; 147(2):253-63. PubMed ID: 2416113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic peptides to identify antigenic determinants on Epstein-Barr virus gp350/220.
    Bertoni G; Kostyal DA; Reisert PS; Humphreys RE; Sairenji T
    Intervirology; 1990; 31(5):290-4. PubMed ID: 1703134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies.
    Tsai CH; Glaser R
    Intervirology; 1991; 32(6):376-82. PubMed ID: 1657827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L; Kwa D; El-Guindy A; Miller G
    J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of Epstein-Barr virus. I. Characterization of viral DNA.
    Lin JC; Shaw JE; Smith MC; Pagano JS
    Virology; 1979 Nov; 99(1):183-7. PubMed ID: 227161
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.
    Hoffman GJ; Lazarowitz SG; Hayward SD
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2979-83. PubMed ID: 6248876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoprecipitation of Epstein-Barr virus EBNA1 protein using human polyclonal serum.
    Wang SC; Hammarskjöld ML; Klein G
    J Virol Methods; 1986 Jul; 13(4):323-32. PubMed ID: 3018021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.